Intrauterine growth restriction, soluble fms-like tyrosine kinase-1 to placental growth factor ratio increase and preeclampsia

Huppertz, 2008, Placental origins of preeclampsia, Hypertension, 51, 970, 10.1161/HYPERTENSIONAHA.107.107607 Ness, 2006, Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia, Am J Obstet Gynecol, 195, 40, 10.1016/j.ajog.2005.07.049 Uzan, 2000, New classification for analysing uterine doppler waveforms during pregnancy: is it useful?, Fetal Diagn Ther, 15, 251, 10.1159/000021016 Van Helden, 2015, Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia, Clin Biochem, 48, 1113, 10.1016/j.clinbiochem.2015.06.020 Verlohren, 2014, New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia, Hypertension, 63, 346, 10.1161/HYPERTENSIONAHA.113.01787 Maynard, 2003, Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia, J Clin Invest, 111, 649, 10.1172/JCI17189 Venkatesha, 2006, Soluble endoglin contributes to the pathogenesis of preeclampsia, Nat Med, 12, 642, 10.1038/nm1429 Stepan, 2004, Soluble fms-like tyrosine kinase 1, N Engl J Med, 18, 2241, 10.1056/NEJM200411183512123 Moldenhauer, 2003, The frequency and severity of placental findings in women with preeclampsia are gestational age dependent, Am J Obstet Gynecol, 189, 1173, 10.1067/S0002-9378(03)00576-3 Kwiatkowski, 2017, Maternal endothelial damage as a disorder shared by early preeclampsia, late preeclampsia and intrauterine growth restriction, J Perinat Med, 45, 793, 10.1515/jpm-2016-0178 Herraiz, 2014, Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction, Obstet Gynecol, 124, 265, 10.1097/AOG.0000000000000367 Stepan, 2007, Maternal plasma concentrations of soluble endoglin in pregnancies with intrauterine growth restriction, J Clin Endocrinol Metab, 92, 2831, 10.1210/jc.2006-2774 Alahakoon, 2014, Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles, J Matern Fetal Neonatal Med, 27, 1854, 10.3109/14767058.2014.880882